Acurx Pharmaceuticals, Inc. (ACXP) has 13 open-market insider trades by 6 insiders since 2021. The most active filer is Carl Sailer, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| David P. Luci | CEOPres | — | 3 | $275K | 2025-01-06 |
| Robert J. Deluccia | Dir10% Owner | — | 3 | $275K | 2025-01-06 |
| Carl Sailer | Dir | — | 4 | $275K | 2025-01-06 |
| Joseph C. Scodari | Dir | — | 1 | $25K | 2025-01-06 |
| Jack H. Dean | Dir | — | 1 | $10K | 2025-01-06 |
| James J. Donohue | Dir | — | 1 | $10K | 2025-01-06 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| James J. Donohue | Director | Buy | $10K | 2025-01-06 |
| Carl Sailer | Director | Buy | $25K | 2025-01-06 |
| Robert J. Deluccia | Director & 10% Owner | Buy | $100K | 2025-01-06 |
| Carl Sailer | Director | Buy | $150K | 2022-07-27 |
| Carl Sailer | Director | Buy | $25K | 2021-11-23 |
| Robert J. Deluccia | Director & 10% | Buy | $25K | 2021-11-19 |
Companies that share insiders with ACXP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| David P. Luci | President & 10% | Buy | $25K | 2021-11-19 |
| Carl Sailer | Director | Buy | $75K | 2021-06-29 |